Abstract #4378

Feasibility of USPIO enhanced 7 Tesla MRI for detecting lymph node metastases in prostate cancer

Bart WJ Philips¹, Rutger CH Stijns¹, Sören Johst², Stephan Orzada², Ansje S Fortuin¹, Jelle O Barentsz¹, Marnix C Maas¹, and Tom WJ Scheenen¹

¹Radiology and Nuclear Medicine, Radboud University Medical Centre Nijmegen, Nijmegen, Netherlands, ²Erwin L. Hahn Institute for MR Imaging, University of Duisburg-Essen, Essen, Germany

Ultrahigh field MRI offers opportunities for USPIO enhanced MRI for diagnosing lymph node metastases in prostate cancer, by improving resolution and increasing the sensitivity to USPIO particles. The assessment of lymph nodes based on size, shape and USPIO uptake can improve the differentiation between non-cancer and metastatic lymph nodes and may also lower the detection size limit for metastatic nodes. In this work we show the first results of USPIO enhanced MRI and computed echo time imaging of patients with high risk prostate cancer at 7 Tesla.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.